Clinical Trials
3 trialsNCT06816992 2026-04-24
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
ORIC Pharmaceuticals
Phase 1 Recruiting
NCT06507306 2026-02-06
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Phase 1 Recruiting
NCT06632236 2025-04-25
5G-EMERALD
Institute of Cancer Research, United Kingdom
Phase 1 Recruiting